Have you ever wanted to meet your virtual twin?
If you’ll be at CES 2022, January 5-8 in Las Vegas, you’ll have your chance!
Visitors to our booth (#8715) will go on a journey to discover the possibilities virtual twins of the human body hold to revolutionize healthcare. By engaging in three interactive experiences, they’ll leave with a solid understanding about the next horizon in life sciences and healthcare: where it’s possible to visualize, test, understand and predict what cannot be seen, from the way drugs affect a disease to surgical outcomes before a patient is treated.
The experience starts when a visitor has their photo taken, which is transformed into a larger-than-life virtual twin of their head. This mirror image becomes translucent until it reveals a rotatable brain that pulsates in colors and patterns, symbolizing various disease states. Next, the visitor sees an animation of a heart which increases in size with every beat until it expands into particles that reveal the silhouette of the visitor, who can then interact with their virtual twin before it dissolves into a data cloud.
Visitor can also participate in augmented reality experiences that demonstrate the Living Heart and the Living Brain – two initiatives currently being used by researchers, device manufacturers and doctors to develop highly accurate virtual models for reproducing conditions and testing treatment options. People can hold, rotate and squeeze a 3D-printed replica of a heart and a brain fitted with embedded sensors and processing components. These models are mirrored in real-time on a connected touchscreen. The physical heart model measures the visitor’s heart rate, while its virtual twin pulsates on screen to match their heartbeat and display their heart rate. As the visitor interacts with the physical model of the brain, they can explore and learn about its hemispheres via the virtual twin.
In addition to these experiences, visitors to our booth can join a mock clinical trial to discover how our MEDIDATA solutions are being used to develop the world’s top pharmaceuticals and vaccines.
- White paper:
- Column: A New Healthcare Reference